Evidence map›Paper›PMID 41286353›Full record

ArticleCommunications biology2025

Molecular mechanisms limiting the AAV gene therapy treatment window in mouse models of blue cone monochromacy.

Brooke A Brothers, Emily R Sechrest, Li Ma, Madyson E Ashcraft, Tongju Guan, Robert J Barbera, Lee M Shaw, Becky Chen, Wolfgang Baehr, Gangqing Hu and 2 more

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Brooke A Brothers *Department of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV, USA.ORCID http://orcid.org/0000-0002-5846-804X
Emily R Sechrest *Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
Li Ma *Department of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, USA.
Madyson E Ashcraft *Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
Tongju GuanDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
Robert J BarberaDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
Lee M ShawDepartment of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
Becky ChenDepartment of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV, USA.
Wolfgang BaehrDepartment of Ophthalmology, John A. Moran Eye Center, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
Gangqing HuDepartment of Microbiology, Immunology, and Cell Biology, West Virginia University, Morgantown, WV, USA.ORCID http://orcid.org/0000-0001-5453-6888
Peter StoilovDepartment of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV, USA.ORCID http://orcid.org/0000-0003-1108-7271
Wen-Tao DengDepartment of Biochemistry and Molecular Medicine, West Virginia University, Morgantown, WV, USA. wen.deng@hsc.wvu.edu.ORCID http://orcid.org/0000-0002-9357-0656

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI JUDITH FEINBERG · 2012 to 2026
$81.0M
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI Travis Salisbury · 2012 to 2026
$61.1M
WVU Flow Cytometry and Single Cell Core Facility (FCSCCF)P20GM121322 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Dominique Bollino · 2018 to 2026
$22.4M
VS-CoBRE Administrative CoreP20GM144230 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Shian Liu · 2022 to 2026
$13.9M
RETINAL PHOTORECEPTOR CYCLIC GMP PHOSPHODIESTERASER01EY008123 · NEI · UNIVERSITY OF UTAH · PI BAEHR, WOLFGANG · 1990 to 2019
$7.8M
Photoreceptor neuron specific alternative splicing of messenger RNAR01EY025536 · NEI · WEST VIRGINIA UNIVERSITY · PI RAMAMURTHY, VISVANATHAN, STOILOV, PETER · 2016 to 2023
$3.3M
Disease mechanisms of cone opsin mutants and treatment strategiesR01EY030056 · NEI · WEST VIRGINIA UNIVERSITY · PI DENG, WEN-TAO · 2019 to 2023
$1.9M
Recombinase-free conditional knock-in through alternative splicingR21EY036144 · NEI · WEST VIRGINIA UNIVERSITY · PI STOILOV, PETER · 2024 to 2025
$418k
Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) EY014800-039003NEI NIH HHS R01 EY008123NEI NIH HHS R01 EY025536NEI NIH HHS R01 EY030056NEI NIH HHS R21 EY036144NIGMS NIH HHS P20 GM103434NIGMS NIH HHS P20 GM121322NIGMS NIH HHS P20 GM144230NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

Blue cone monochromacy (BCM) is a severe X-linked blinding disorder caused by mutations in the OPN1LW/OPN1MW locus, resulting in impaired cone function and structural degeneration. We conduct a comparative analysis of AAV gene therapy in Opn1mw

Indexed as

Color Vision DefectsDependovirusGenetic TherapyRetinal Cone Photoreceptor CellsAnimalsDisease Models, AnimalGenetic VectorsMiceMice, Inbred C57BLMice, KnockoutRod OpsinsRod Opsins

Identifiers

PMID41286353
PMCPMC12644701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.